Obesity, diet and nutraceuticals by unknown
INVITED SPEAKER PRESENTATION Open Access
Obesity, diet and nutraceuticals
Cherubino Di Lorenzo1*, Gianluca Coppola2
From Abstracts from the 1st Joint ANIRCEF-SISC Congress
Rome, Italy. 29-31 October 2015
Migraine is the most prevalent neurological disorder
worldwide, affecting on average 12% of the general popula-
tion. Recent data support migraine as part of the metabolic
syndrome (MetSyn) spectrum. The evidence of an associa-
tion between obesity, insulin resistance, and migraine, all
having in common the ability to favor a general pro-
inflammatory state, reinforces this view. Under a neuronal
point of view, another possible link between migraine and
MetSyn is, other than the inflammatory state, the cellular
energetic deficit. Indeed, it is well known that a mitochon-
drial energetic dysfunction may play a role in migraine
pathogenesis, that MetSyn could further impair mitochon-
drial metabolism increasing oxidative stress, and that
nutraceuticals involved in mitochondrial oxidative phos-
phorylation (OXPHOS) metabolism (Riboflavin, CoQ10,
and magnesium) can be used as migraine prophylactic
treatments. Here we review the evidence of MetSyn and
migraine association and possible therapeutic implications.
There is a close relationship between migraine and
MetSyn, especially insulin resistance and obesity. More in
detail, obesity is regarded as an important factor of chroni-
fication for migraineur patients, while weight-loss seems to
have a protective effect. The main player of this associa-
tion seems to be the obesity-related inflammation and an
adequate slimming diet can act to reduce this inflamma-
tory mechanism. In fact, inflammatory cytokines are
higher in obese subjects and normalized by weight reduc-
tion. Moreover, several foods could act as triggers for
some patients by an inflammatory antibody mediated
pathway, by a direct histamine or other vasoactive peptides
effect, or by modifying the quality and quantity of fat
intake. Also, altered insulin metabolism could be related
to leptins and nitric oxide (NO) stress, both inducing
inflammatory effects involved in migraine pathogenesis.
Some prophylactic treatments induce increase of weight,
insulin and leptins that can counteract the therapeutic
effect; it is the “prophylactic paradox”: a long lasting
migraine could be worsened by the drug-induced obesity.
Therefore, there is the rationale for the adoption of
specific dietetic patterns as complementary treatment in
migraine management. In particular, the ketogenic diet
is worthy of mention because of its multiple effects on
the above-mentioned mechanisms, since it induces a sig-
nificant weight-loss (when prescribed as very-low calorie
diet), normalizes leptins and hyperinsulinemia, improves
mitochondrial OXPHOS metabolism, and has a ketone
bodies induced anti-inflammatory effect.
In summary, more attention should be paid to metabolic
implications of migraine and its treatment to further
improve, or at least not worsen, patients’ conditions and
reduce migraine-related comorbidities and complications.
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